GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Cash per Share

DCF Cash per Share : $0.13 (As of Aug. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Cash per Share?

Cash per Share is calculated as Balance Sheet Cash And Cash Equivalents divided by Shares Outstanding (EOP). BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Cash per Share for the quarter that ended in Aug. 2024 was $0.13.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Cash per Share Historical Data

The historical data trend for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Cash per Share Chart

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Cash per Share
Get a 7-Day Free Trial 0.01 0.24 0.01 0.24 0.13

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Semi-Annual Data
Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.07 0.24 0.04 0.13

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Cash per Share for the fiscal year that ended in Aug. 2024 is calculated as:

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Cash per Share for the quarter that ended in Aug. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund  (NYSE:DCF) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Cash per Share Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Traded in Other Exchanges
N/A
Address
c/o BNY Mellon Investment Adviser, Inc, 240 Greenwich Street, New York, NY, USA, 10286
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date. It has a dynamic, multi-asset portfolio designed to access multiple sub-investment grade credit opportunities for enhanced yield potential with active risk management.
Executives
Bushra Mannan other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang other: Dir. of Invest. Oversight (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak officer: President 200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella officer: VP C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein officer: VP 240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy officer: VP; Investment Adviser C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel other: Head of Finance of Sub-Adviser 200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc other: Sub-Adviser 200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson other: Portfolio Mgr of Sub-Adviser C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166